Dobson's Sports Clinic

The American College of Sports Medicine (ACSM) just released a roundtable statement, redefining the 5 Pillars of Physical Fitness for the modern world.

For decades, we’ve split fitness into "health-related" and "skill-related" categories. But the science has evolved: balance, agility, and power aren't just for athletes anymore—they are essential for everyone’s long-term health.

The new 5 Pillars of Physical Fitness you need to know:
1️⃣ Cardiorespiratory Fitness (CRF): The "gold standard" for longevity. It’s your heart and lungs' ability to power you through life without hitting a wall.
2️⃣ Muscular Fitness: No longer just "strength." This integrated pillar combines strength, endurance, and power to keep your muscles functional and resilient.
3️⃣ Body Composition: It’s about more than the scale. This focuses on the ratio of fat mass to fat-free mass (like bone and muscle), which is critical for metabolic health.
4️⃣ Neuromotor Fitness: Formerly "skill-related," this now-essential pillar includes balance, agility, and gait speed to prevent falls and keep you moving confidently as you age.
5️⃣ Flexibility: The ability to move your joints through a full, pain-free range of motion—vital for performing daily activities safely.

Why this matters:
⓵ They are ALL Interconnected: Improving your strength can actually improve your balance; aerobic exercise can improve your gait.
⓶ It’s Individualized: Your fitness "blueprint" should change based on your goals. An older adult might prioritize neuromotor balance, while a younger runner focuses on CRF.
⓷ It’s About Health: Every one of these components are shown to reduce the risk of chronic disease and improve mental health.

Indian Society of Sport and Exercise Medicine (ISSEM)
Webinar.

*Shared Decision Making In Sports Cardiology*

Speaker: *Dr Ankit Shah, Founder and President, Sports and Performance Cardiology, Chevy Chase, USA*
Event Timing: *06:00 PM IST, June 25th, 2026*

Contact us at [email protected] or
+91 94178 06332

Registration fees: Free for ISSEM members, Rs 200/- for non ISSEM members

Registration link: https://docs.google.com/forms/d/e/1FAIpQLSe4JwEe1mCT8kQ36LqnlqLb-rDkUKNF3pto_z8Qb5ZIuBiyfA/viewform

𝐀𝐧 𝐈𝐂𝐃 𝐝𝐨𝐞𝐬 𝐧𝐨𝐭 𝐩𝐫𝐞𝐯𝐞𝐧𝐭 𝐚𝐫𝐫𝐡𝐲𝐭𝐡𝐦𝐢𝐚𝐬—𝐢𝐭 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐬 𝐬𝐮𝐝𝐝𝐞𝐧 𝐜𝐚𝐫𝐝𝐢𝐚𝐜 𝐝𝐞𝐚𝐭𝐡. 🫀

Christian Eriksen’s longitudinal journey is the ultimate case study in modern sports cardiology, illustrating the fine line between electrical vulnerability and technological triumph.
As broken down in the infographic, his timeline marks a critical clinical evolution:
1️⃣ 2021 | 𝐓𝐡𝐞 𝐄𝐱𝐭𝐞𝐫𝐧𝐚𝐥 𝐑𝐞𝐬𝐜𝐮𝐞 (𝐄𝐮𝐫𝐨 2020): Sudden cardiac arrest (VF) on the pitch. Survival relied entirely on an external chain of survival—immediate bystander CPR and an AED shock—leading to secondary prevention via ICD implantation.

2️⃣ 2022 | 𝐓𝐡𝐞 𝐏𝐚𝐬𝐬𝐢𝐯𝐞 𝐆𝐮𝐚𝐫𝐝𝐢𝐚𝐧 (𝐖𝐨𝐫𝐥𝐝 𝐂𝐮𝐩): A historic, successful "Return-to-Play." The ICD remained in "watch mode" during elite competition, proving perfect electrical stability under high-intensity stress.

3️⃣ 2026 | 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐢𝐧 𝐀𝐜𝐭𝐢𝐨𝐧 (𝐑𝐞𝐜𝐞𝐧𝐭 𝐄𝐯𝐞𝐧𝐭): Recurrent arrhythmia triggered under extreme metabolic and adrenoceptor stress. This time, the rescue was entirely internal. The ICD detected and treated the event, restoring sinus rhythm in seconds. The athlete was conscious and walked off safely.

💡 𝐓𝐡𝐞 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲 𝐟𝐨𝐫 𝐒𝐩𝐨𝐫𝐭𝐬 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞

The 2022 comeback showed us what is 𝐩𝐨𝐬𝐬𝐢𝐛𝐥𝐞 with rigorous stratification. The 2026 event reminded us why the technology is 𝐧𝐞𝐜𝐞𝐬𝐬𝐚𝐫𝐲.

We cannot always prevent an underlying electrical substrate from triggering a malfunction under elite-level stress, but with early response and advanced technology, we can successfully abort a fatal outcome.

𝐒𝐞𝐜𝐨𝐧𝐝𝐚𝐫𝐲 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐬𝐚𝐯𝐞𝐬 𝐥𝐢𝐯𝐞𝐬.

🏸 Why do many sports scientists consider badminton one of the most physically demanding racket sports?

The answer lies in its unique combination of explosive speed, near-maximal cardiovascular stress, rapid changes of direction, powerful jumping and landing forces, and constant cognitive decision-making.

A badminton player must think like a chess player, move like a sprinter, jump like a volleyball athlete, and sustain it all for the duration of a match.

🏸 The shuttlecock is the fastest projectile in sport.

✓ Elite smash speeds exceed 400 km/h
✓ World record smash speed exceeds 560 km/h
✓ Players have less than 0.5 seconds to perceive, decide, and react

Although the court is smaller than tennis:

✓ Hundreds of explosive accelerations
✓ Continuous lunges, jumps, and directional changes
✓ Up to 1,500–2,000 changes of direction per hour

The game never allows the body to settle into a rhythm.

Sports science studies show:

❤️ Match heart rates frequently reach 85–95% of maximum
❤️ Elite rallies repeatedly push athletes toward maximal aerobic capacity
❤️ High-intensity bursts are sustained for entire matches

Badminton combines sprinting demands with endurance requirements.

Every jump smash and recovery step creates:

⚡ High ground reaction forces
⚡ Repeated loading of knees, ankles, hips, and spine
⚡ Hundreds of powerful eccentric muscle contractions

Athletes need strength, elasticity, and resilience—not just fitness.

Elite badminton demands:

🧠 Anticipation
🧠 Pattern recognition
🧠 Split-second tactical decisions
🧠 Precision under fatigu

Badminton challenges the visual, neurological, and musculoskeletal systems simultaneously.

The science is clear: badminton is far more than “just hitting a shuttle.”

are no longer fringe science

Sports medicine is entering a difficult scientific era: peptide use is growing faster than the evidence base.

From recovery clinics to online “biohacking” communities, athletes and recreational exercisers are increasingly using injectable peptides for fat loss, recovery, muscle preservation, tendon healing, sleep, and performance enhancement. Yet much of this use is occurring outside regulated clinical systems, with compounds sourced from loosely regulated online markets and “research chemical” suppliers.

The core problem is not simply that peptides exist — it is that real-world adoption has dramatically outpaced high-quality human research.

Current scientific evidence suggests:
• Some peptides show biologically plausible therapeutic potential.
• A few have legitimate medical indications.
• Many remain poorly studied in humans.
• Long-term safety data are largely absent.
• Product quality and dosing consistency are major concerns.
• Sports performance claims are often exaggerated beyond available evidence.

From a sports medicine perspective, peptides can broadly be grouped into:

1. Evidence-Backed Medical Peptides

These include compounds with approved clinical roles:
• GLP-1 receptor agonists for obesity/metabolic disease
• Certain growth hormone secretagogues in endocrine disorders
• Peptide-based therapies in diabetes and osteoporosis

These agents are increasingly relevant to athlete health, body composition, metabolic rehabilitation, and injury management — but must be used within established medical frameworks.

2. Experimental Recovery & Performance Peptides

Examples commonly discussed in sport include:
• BPC-157
• TB-500 / Thymosin beta-4
• CJC-1295
• Ipamorelin
• MOTS-c
• AOD-9604

The issue is that most claims surrounding these compounds rely on:
• animal studies,
• mechanistic theory,
• anecdotal reports,
• uncontrolled case experiences,
rather than robust randomized human trials.

For many of these peptides:
• pharmacokinetics remain uncertain,
• optimal dosing is unknown,
• interaction profiles are poorly characterized,
• and long-term endocrine, cardiovascular, hepatic, or oncologic effects remain unclear.

The Research Bottleneck

A major challenge highlighted by researchers is regulatory and financial barriers to conducting peptide trials properly.

Conducting human studies often requires:
• GMP-grade manufacturing,
• regulatory toxicology packages,
• ethics approval,
• extensive safety monitoring,
• and substantial funding.

This creates a paradox:
• public use accelerates rapidly,
• underground markets expand,
• but formal science struggles to keep pace.

As a result, athletes frequently become uncontrolled real-world experiments without surveillance systems capable of detecting harm early.

Key Sports Medicine Concerns

1. Product Purity & Contamination

Independent analyses of unregulated peptides have demonstrated:
• inaccurate labeling,
• contamination,
• incorrect peptide sequences,
• endotoxin risk,
• variable concentration.

Athletes may unknowingly inject substances very different from what labels claim.

2. Anti-Doping Risk

Many peptides fall under prohibited categories within the World Anti-Doping Agency framework:
• growth hormone secretagogues,
• growth factors,
• IGF-related compounds,
• certain metabolic modulators.

Even contamination or undeclared ingredients can trigger anti-doping violations.

3. Lack of Long-Term Safety Data

Potential concerns include:
• endocrine dysregulation,
• insulin resistance,
• edema,
• cardiovascular strain,
• fibrosis,
• altered tumor signaling pathways.

Current evidence is insufficient to confidently define long-term risk profiles for many compounds.

What the Scientific Community Increasingly Agrees On

A balanced modern sports medicine position is emerging:
• Blanket dismissal of all peptides is scientifically unhelpful.
• Uncritical promotion of peptides as “miracle recovery tools” is equally problematic.
• Controlled human research is urgently needed.
• Regulation must evolve faster than current academic systems.
• Athlete safety requires evidence, not hype.

The future likely lies in:
• better translational peptide science,
• stricter manufacturing standards,
• registry-based monitoring,
• precision medicine approaches,
• and carefully designed clinical trials in athletic populations.

Until then, the peptide landscape remains a collision between: rapid commercialization,
social-media-driven demand anti-doping regulation,
and incomplete science

Tech Doping or Future of Sports Performance?

The emergence of carbon-plated “super shoes” like the Adidas Adizero Adios Pro Evo 1 has fundamentally altered the biomechanics and physiology of distance running. The question is no longer if they improve performance—but how.

1. Running Economy: The Core Mechanism

Running economy (oxygen cost at a given speed) is the strongest predictor of endurance performance.

Super shoes improve economy by ~3–5%, which at elite level translates into minutes over a marathon.

Mechanisms:
• High energy return foams → Reduced energy dissipation
• Carbon plate stiffness → Optimized force transfer
• Rocker geometry → Reduced ankle joint work

👉 Net effect: Lower metabolic cost for the same velocity

⸻

2. Biomechanical Efficiency

These shoes fundamentally alter lower-limb mechanics:
• Reduced ankle dorsiflexion moment
• Shift of work from ankle → knee/hip
• Increased stride length with maintained cadence
• Improved elastic energy storage (Achilles–tendon complex)

This creates a more “spring-mass optimized” system, reducing muscular fatigue over long distances.

⸻

3. Muscle-Tendon Interaction

Super shoes enhance elastic recoil efficiency:
• Foam + plate act like an external tendon
• Reduces reliance on active muscle work
• Delays onset of neuromuscular fatigue

👉 Particularly critical beyond 30 km in marathon physiology

⸻

4. Exercise Physiology Impact

From a physiological standpoint:
• ↓ VO₂ at submaximal speeds
• ↓ lactate accumulation at race pace
• ↑ time to exhaustion
• ↓ perceived exertion

This effectively raises the sustainable speed ceiling without changing VO₂ max.

⸻

5. Performance Translation

A 3–4% improvement in running economy can:
• Convert a 2:04 marathoner → sub-2:00 potential under ideal conditions
• Redefine pacing strategies
• Compress elite competition margins

⸻

6. The Controversy: “Tech Doping”?

Unlike pharmacological doping:
• These gains are mechanical, not biological
• Benefits are accessible but not equal (cost, availability, adaptation)

However, the magnitude of improvement raises a valid question:

At what point does equipment redefine human performance limits?

⸻

7. Practical Sports Medicine Perspective

For clinicians and performance teams:
• Expect load redistribution injuries (calf ↓, hip/knee ↑)
• Monitor Achilles and soleus adaptation patterns
• Progressive integration is essential—not plug-and-play

⸻

Bottom Line

Super shoes do not just make athletes faster—
they re-engineer the energetics of human running.

The real debate is not whether they work.
It’s whether we are still measuring the athlete—or the system.